Lakefront Biotherapeutics Welcomes Dr. Mehdi Shahidi to its Board of Directors
manilatimes.net · 2026-11-02
Dr. Shahidi brings extensive drug development experience, regulatory success, and transformative operational expertise to the Board
Read the full story at manilatimes.net →
Is CVAC undervalued? See TickrTrends' fair value analysis →